Text Size

Improving stability of tear film lipid layer via concerted action of two drug molecules: A biophysical view

Eftimov P., Olżyńska A., Melcrová A., Georgiev G.As., Daull P., Garrigue J.-S., Cwiklik L.

  • 2020
  • International Journal of Molecular Sciences
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Preclinical development

  • Affiliations

    Department of Cytology and Embryology, Faculty of Biology, University of Sofia, Sofia, 1504, Bulgaria; J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, Prague, 18223, Czech Republic; iBB—Institute for Bioengineering and Biosciences, Complexo Interdisciplinar, IST, Universidade de Lisboa, Lisbon, 1649-004, Portugal; SANTEN SAS, Novagali Innovation Center, 1, rue Pierre Fontaine, Bâtiment Genavenir IV, Evry CEDEX, F-91458, France; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, 16610, Czech Republic

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022